Corteva Agriscience launches two products for rice sector in Brazil

Corteva Agriscience is enhancing its performance in the rice sector, with Brazil being the largest consumer of the grain outside Asia, through the launch of two new products, the fungicide, Bim Max (200 g/L tricyclazole + 160 g/L tebuconazole), and the herbicide, Raster (cyhalofop-butyl + penoxsulam). The company operates in the rice segment by offering several solutions to increase productivity in the field and is continuing to invest in an increasingly robust and complete market portfolio.

Bim Max offers technology solutions and practicality to farmers in terms of combating the main diseases affecting rice cultivation, which have a high potential for damage and drastically reduce productivity. A combination of two active ingredients, tricyclazole and tebuconazole, the fungicide acts with a systemic mode of action and has a broad spectrum of disease control on both leaves and grains.

The second launch is the herbicide, Raster, which is also a combination of two active ingredients, cyhalofop-butyl and penoxsulam, offering greater efficiency while having a selective and systemic mode of action for controlling weeds that affect rice, such as grassy weeds and broad leaves weeds. Raster has a broad spectrum of pre and post-emergent control.

“The rice sector has been developing over the years and is gaining more and more prominence, and we are proud to say that we are part of this evolution. Corteva believes in rice and is always looking to help and support rural producers in improving their profitability through our technologies,” said Luiz Grines, Portfolio Leader for the Rice Line at Corteva Agriscience.

Bim Max and Raster will add to Corteva's robust herbicide and fungicide portfolio for rice cultivation. The company's previous launch in the segment was the herbicide, Loyant, a key tool for controlling resistant rice weeds that was highly expected by the entire market. The launch of the Arroz Line is also part of Corteva's innovation efforts, with an annual investment of US$1.2 billion in research and development, of which 200 million went to Brazil.